BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 18823825)

  • 1. Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Minkin P; Zhao M; Chen Z; Ouwerkerk J; Gelderblom H; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Oct; 874(1-2):84-8. PubMed ID: 18823825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of unbound sunitinib and its metabolite N-desethyl sunitinib (SU12662) in human plasma by equilibrium dialysis and liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
    Rais R; Zhao M; He P; Xu L; Deeken JF; Rudek MA
    Biomed Chromatogr; 2012 Nov; 26(11):1315-24. PubMed ID: 22259028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioanalytical method for the quantification of sunitinib and its n-desethyl metabolite SU12662 in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.
    de Bruijn P; Sleijfer S; Lam MH; Mathijssen RH; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2010 Mar; 51(4):934-41. PubMed ID: 19931354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of sunitinib and its active metabolite, N-desethyl sunitinib in mouse plasma and tissues by UPLC-MS/MS: assay development and application to pharmacokinetic and tissue distribution studies.
    Chen X; Wang Z; Liu M; Liao M; Wang X; Du H; Chen J; Yao M; Li Q
    Biomed Chromatogr; 2015 May; 29(5):679-88. PubMed ID: 25294592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay.
    Zhao M; Rudek MA; He P; Hafner FT; Radtke M; Wright JJ; Smith BD; Messersmith WA; Hidalgo M; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):1-7. PubMed ID: 16798122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A liquid chromatography/tandem mass spectrometry assay to quantitate MS-275 in human plasma.
    Zhao M; Rudek MA; Mnasakanyan A; Hartke C; Pili R; Baker SD
    J Pharm Biomed Anal; 2007 Jan; 43(2):784-7. PubMed ID: 16971082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of sunitinib and its two metabolites in plasma of Chinese patients with metastatic renal cell carcinoma by liquid chromatography-tandem mass spectrometry.
    Qiu F; Bian W; Li J; Ge Z
    Biomed Chromatogr; 2013 May; 27(5):615-21. PubMed ID: 23108983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry.
    Zhao M; Hartke C; Jimeno A; Li J; He P; Zabelina Y; Hidalgo M; Baker SD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):73-80. PubMed ID: 15797523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and implementation of a method for determination of bryostatin 1 in human plasma by using liquid chromatography/tandem mass spectrometry.
    Zhao M; Rudek MA; He P; Smith BD; Baker SD
    Anal Biochem; 2005 Feb; 337(1):143-8. PubMed ID: 15649387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a liquid chromatography/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study.
    Rodamer M; Elsinghorst PW; Kinzig M; Gütschow M; Sörgel F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(11-12):695-706. PubMed ID: 21367676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatography-mass spectroscopy/mass spectroscopy method for simultaneous quantification of total or free fraction of mycophenolic acid and its glucuronide metabolites.
    Figurski MJ; Korecka M; Fields L; Waligórska T; Shaw LM
    Ther Drug Monit; 2009 Dec; 31(6):717-26. PubMed ID: 19809389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine.
    Marangon E; Buzzo M; Posocco B; Gagno S; Zanchetta M; Iacuzzi V; Poetto AS; Guardascione M; Giodini L; Toffoli G
    J Pharm Biomed Anal; 2020 Feb; 179():112949. PubMed ID: 31784210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid analysis of tadalafil in human blood plasma and seminal plasma by liquid chromatography/tandem mass spectrometry.
    Ma B; Shang X; Zhang Q; Li J; Liu Y; Cao X; Xu Q
    J Pharm Biomed Anal; 2013 Apr; 77():149-57. PubMed ID: 23416369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of iptakalim in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Teng G; Wang Y; Tang Y; Wang R; Fang Y; Fawcett JP; Gu J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(2):256-60. PubMed ID: 17913597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of sunitinib in human plasma using liquid chromatography coupled with mass spectrometry.
    Musijowski J; Piórkowska E; Rudzki PJ
    J Sep Sci; 2014 Oct; 37(19):2652-8. PubMed ID: 25044855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of subutinib and its active metabolite in human plasma by LC-MS/MS: Application to pharmacokinetic study.
    Ding LK; Yang L; Chen SN; Li JK; Wen AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():22-6. PubMed ID: 26253807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultra-performance liquid chromatography/tandem mass spectrometry method for the determination of lercanidipine in human plasma.
    Kalovidouris M; Michalea S; Robola N; Koutsopoulou M; Panderi I
    Rapid Commun Mass Spectrom; 2006; 20(19):2939-46. PubMed ID: 16941725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of DMXAA in human and mouse plasma.
    Zhang X; Zhao M; Rudek MA; He P; Vogelstein B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):217-22. PubMed ID: 17307035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a rapid and sensitive UPLC-MS/MS assay for the quantification of tofacitinib in human plasma.
    Bharwad KD; Shah PA; Shrivastav PS; Singhal P
    Biomed Chromatogr; 2019 Apr; 33(4):e4458. PubMed ID: 30520053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of zofenopril and its active metabolite zofenoprilat in human plasma.
    Jiang Y; Yan F; Di B; Feng F; You L; Huang L; Lu J
    J Pharm Biomed Anal; 2011 Jun; 55(3):527-32. PubMed ID: 21377823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.